The high tissue retention associated with albumin nanoparticles may be useful for therapeutic regimes such as lung cancer treatment with inhaled nanomedicines [26], which would benefit patients by providing high, sustained drug concentrations in the lung tissue and low systemic drug exposure. This evidence concerns the gene ALB and lung cancer.